Abvc Biopharma (ABVC) Total Non-Current Liabilities (2019 - 2026)
Abvc Biopharma (ABVC) recorded Total Non-Current Liabilities of $7.1 million in Q2 2026, up 5.8% from $6.71 million a year earlier.
Powered by 
Analysis
Abvc Biopharma (ABVC) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
At the end of FY2025, Abvc Biopharma reported Total Non-Current Liabilities of $123,017, up 7.0% from FY2024.
- Annual Total Non-Current Liabilities has a five-year compound annual growth rate of 1.9% (FY2020 to FY2025).
- Across earlier years, Total Non-Current Liabilities came in at $114,925 in FY2024 (-67.0%), $348,004 in FY2023 (+228.7%), $105,888 in FY2022 (+225.6%) and $32,522 in FY2021 (-71.0%).
- The Q2 2026 figure is the highest quarterly Total Non-Current Liabilities in data going back to Q1 2019.
- On a year-over-year basis, Total Non-Current Liabilities rose in three of the last four quarters, with an average decline of 11.2%.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 228.7% in Q4 2023, against a decline of 92.4% in Q1 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - | 7.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.10 Mn |
| Dec 31, 2025 | 123,017.00 |
| Sep 30, 2025 | 6.68 Mn |
| Jun 30, 2025 | 6.71 Mn |
| Mar 31, 2025 | 6.90 Mn |
| Dec 31, 2024 | 114,925.00 |
| Sep 30, 2024 | 6.11 Mn |
| Jun 30, 2024 | 105,548.00 |
| Mar 31, 2024 | 103,102.00 |
| Dec 31, 2023 | 348,004.00 |
| Sep 30, 2023 | 368,099.00 |
| Jun 30, 2023 | 368,270.00 |
| Mar 31, 2023 | 359,198.00 |
| Dec 31, 2022 | 105,888.00 |
| Sep 30, 2022 | 120,601.00 |
| Jun 30, 2022 | 113,615.00 |
| Mar 31, 2022 | 4.70 Mn |
| Dec 31, 2021 | 32,522.00 |
| Sep 30, 2021 | 49,905.00 |
| Jun 30, 2021 | 78,440.00 |
API Access
Abvc Biopharma Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();